Immature dendritic cells (iDCs) do not mature after uptake of apoptotic cells and may play a role in the induction of peripheral tolerance to self antigens derived from apoptotic material. The integrins, αvβ3, αvβ5, and the scavenger receptor, CD36, have been shown to mediate uptake of apoptotic cells by iDCs. However, it is not known whether the complement system, also takes part in this process. In this study we investigated the ability of iDCs to bind to apoptotic cells opsonized by iC3b. Monocyte-derived dendritic cells were offered apoptotic Jurkat cells opsonized by autologous iC3b and labeled with 1,1′-dioctadecyl-3,3,3′,3′-tetramethyl-indocarbocyanineperchlorate. A significant increase (P < 0.001) in the amount of cleared apoptotic cells was seen at low ratios. Despite increased efficiency of uptake, interaction between iC3b-opsonized apoptotic cells and iDCs down-regulated the expression of major histocompatibility complex class II, CD86, CC chemokine receptor (CCR)2, CCR5, and β2-integrins (P < 0.001), and up-regulated expression of CCR7 (P < 0.001). In addition, iDC maturation responses to CD40L and lipopolysaccharide were significantly inhibited. We conclude that opsonization of apoptotic cells by iC3b induces tolerant iDCs that are able to migrate to lymph nodes.
Skip Nav Destination
Article navigation
16 December 2002
Article|
December 09 2002
Opsonization of Apoptotic Cells by Autologous iC3b Facilitates Clearance by Immature Dendritic Cells, Down-regulates DR and CD86, and Up-regulates CC Chemokine Receptor 7
Inna Verbovetski,
Inna Verbovetski
1The Laboratory for Cellular and Molecular Immunology, Rheumatology Unit, Department of Medicine, Hadassah Hospital and the Hebrew University
Search for other works by this author on:
Hila Bychkov,
Hila Bychkov
1The Laboratory for Cellular and Molecular Immunology, Rheumatology Unit, Department of Medicine, Hadassah Hospital and the Hebrew University
Search for other works by this author on:
Uriel Trahtemberg,
Uriel Trahtemberg
1The Laboratory for Cellular and Molecular Immunology, Rheumatology Unit, Department of Medicine, Hadassah Hospital and the Hebrew University
Search for other works by this author on:
Itzhak Shapira,
Itzhak Shapira
2Sourasky Medical Center, Jerusalem 91120, Israel
Search for other works by this author on:
Mara Hareuveni,
Mara Hareuveni
2Sourasky Medical Center, Jerusalem 91120, Israel
Search for other works by this author on:
Ofira Ben-Tal,
Ofira Ben-Tal
2Sourasky Medical Center, Jerusalem 91120, Israel
Search for other works by this author on:
Ina Kutikov,
Ina Kutikov
2Sourasky Medical Center, Jerusalem 91120, Israel
Search for other works by this author on:
Oranit Gill,
Oranit Gill
1The Laboratory for Cellular and Molecular Immunology, Rheumatology Unit, Department of Medicine, Hadassah Hospital and the Hebrew University
Search for other works by this author on:
Dror Mevorach
Dror Mevorach
1The Laboratory for Cellular and Molecular Immunology, Rheumatology Unit, Department of Medicine, Hadassah Hospital and the Hebrew University
2Sourasky Medical Center, Jerusalem 91120, Israel
Search for other works by this author on:
Inna Verbovetski
1The Laboratory for Cellular and Molecular Immunology, Rheumatology Unit, Department of Medicine, Hadassah Hospital and the Hebrew University
Hila Bychkov
1The Laboratory for Cellular and Molecular Immunology, Rheumatology Unit, Department of Medicine, Hadassah Hospital and the Hebrew University
Uriel Trahtemberg
1The Laboratory for Cellular and Molecular Immunology, Rheumatology Unit, Department of Medicine, Hadassah Hospital and the Hebrew University
Itzhak Shapira
2Sourasky Medical Center, Jerusalem 91120, Israel
Mara Hareuveni
2Sourasky Medical Center, Jerusalem 91120, Israel
Ofira Ben-Tal
2Sourasky Medical Center, Jerusalem 91120, Israel
Ina Kutikov
2Sourasky Medical Center, Jerusalem 91120, Israel
Oranit Gill
1The Laboratory for Cellular and Molecular Immunology, Rheumatology Unit, Department of Medicine, Hadassah Hospital and the Hebrew University
Dror Mevorach
1The Laboratory for Cellular and Molecular Immunology, Rheumatology Unit, Department of Medicine, Hadassah Hospital and the Hebrew University
2Sourasky Medical Center, Jerusalem 91120, Israel
Address correspondence to Dror Mevorach, The Laboratory for Cellular and Molecular Immunology, Department of Medicine Hadassah University Hospital, Kiryat Hadassah, P.O. Box 12000, Jerusalem 91120, Israel. Phone: 972-2-677-6896; Fax: 972-2-643-3935; E-mail: [email protected]
I. Verbovetski and H. Bychkov contributed equally to this work.
*
Abbreviations used in this paper: DIL, 1,1′-dioctadecyl-3,3,3′,3′-tetra-methyl-indocarbocyanineperchlorate; iDC, immature dendritic cell.
Received:
February 19 2002
Revision Received:
October 17 2002
Accepted:
October 24 2002
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2002
J Exp Med (2002) 196 (12): 1553–1561.
Article history
Received:
February 19 2002
Revision Received:
October 17 2002
Accepted:
October 24 2002
Citation
Inna Verbovetski, Hila Bychkov, Uriel Trahtemberg, Itzhak Shapira, Mara Hareuveni, Ofira Ben-Tal, Ina Kutikov, Oranit Gill, Dror Mevorach; Opsonization of Apoptotic Cells by Autologous iC3b Facilitates Clearance by Immature Dendritic Cells, Down-regulates DR and CD86, and Up-regulates CC Chemokine Receptor 7 . J Exp Med 16 December 2002; 196 (12): 1553–1561. doi: https://doi.org/10.1084/jem.20020263
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement